TABLE 1.
Characteristics of Included Studies and Patientsa
| Author (Year) | Study Design (Level of Evidence) | Mean MINORS Score | No. of Patients/Shoulders | Female Sex, % | Age, Mean ± SD (Range), y | Follow-up Time, Mean ± SD (Range), mo |
|---|---|---|---|---|---|---|
| Castricini et al4 (2016) | Retrospective case series (4) | 6 | 86/86 | 44.2 | 59.8 ± 5.9 (38-69) | 36.4 ± 9 (24-60) |
| De Casas et al8 (2014) | Retrospective case series (4) | 6 | 14/14 | 28.6 | 59 (52-66) | 52 (36-77) |
| Grimberg et al14 (2015) | Prospective case series (4) | 7 | 55/55 | 54.5 | 62 (31-75) | 29.4 (24-42) |
| Kanatli et al19 (2017) | Prospective case series (4) | 7 | 15/15 | 53.3 | 61.5 ± 6.2 (52-71) | 26.4 ± 2.6 (24-31) |
| Kany et al20 (2016) | Prospective case series (4) | 7 | 5/5 | 20 | 65 ± 6.5 (58-75) | 17.8 ± 5.3 (12-24) |
| Paribelli et al25 (2015) | Prospective comparative study (2) | 14 | 20/20 | 35 | 62.5 (45-77) | 33.6 ± 36 (12-60) |
| Petriccioli et al28 (2016) | Retrospective case series (4) | 5 | 33/33 | 33.3 | 57.9 (31-69) | 35.7 (12-60) |
| Yamakado36 (2017) | Prospective case series (4) | 7 | 30/30 | 26.7 | 67.4 ± 6.2 (54-78) | 34 (24-72) |
aMINORS, Methodological Index for Non-Randomized Studies.